Journal of Nutrition and Health

The Korean Nutrition Society (한국영양학회)
권호 표지

Effect of Soy Isoflavone Supplementation on Bone Metabolism Marker and Urinary Mineral Excretion in Postmenopausal Women

대두 이소플라본 보충 섭취가 폐경 후 여성의 골대사 지표와 소변 무기질 배설량에 미치는 영향

  • 이다홍 (숙명여자대학교 식품영양학과) ;
  • 승정자 (숙명여자대학교 식품영양학과)
  • Published : 2003.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

We studied the effects of soy isoflavone supplements on bone metabolism marker (serum osteocalcin, urinary deoxypyridinoline) and urinary mineral excretion (urinary Ca, Mg, Zn) in 47 postmenopausal women. There were 24 participants in the treatment group and 23 in the control group. The treatment group consumed isoflavone extract capsules daily (which contained 90 mg of soy isoflavones) for 12 weeks. The study compared before and after isoflavone intake in the following areas: Physical examination, diet survey, bone metabolism marker and urinary mineral excretion. The average age of the treatment group was 64.6 years and that of the control group was 66.5 years. There were no significant differences between the two groups in terms of height, weight and body mass index. Both groups maintained a regular diet pattern in terms of their average daily nutrient intake. There were no significant differences between the treatment group (23.9 mg) and the control group (25.4 mg) in terms of daily isoflavone intake based on diet. The analysis of bone metabolism marker changes in the treatment group after 12 weeks of taking the isoflavone supplements demonstrated significant differences in the following: Serum osteocalcin (13.7 ng/mL in befor versus 6.8 ng/mL in after) and urinary deoxypyridinoline (5.9 nmol/mmol Cr in befor versus 4.5 nmol/mmol Cr in after). The subjects in the treatment group showed no significant difference in urinary Ca excretion. But the subjects showed a significant difference in urinary Mg (131.9 mg/day in befor versus 115.6 mg/day in after) and Zn (400.5 $\mu\textrm{g}$/day in befor versus 310.2 $\mu\textrm{g}$/day in after) excretion in the isoflavone treatment group at the levels of p<0.001, p<0.01, respectively. No changes were made in the intake of minerals. The composition of serum osteocalcin and urinary deoxypyridinoline, and indicators of bone metabolism, including the excretion Mg and Zn, significantly decreased. As a result, bone mineral loss was lessened. (Korean J Nutrition 36(5): 476~482, 2003)

Keywords

References

  1. Complete life Tables Korea National Statistical Office
  2. J Am Coll Nutr v.20 The Role of Phytoestrogens in the Prevention and Treatmant of Osteoporosis in Ovarian Hormone Deficiency Arjmandi,B.H. https://doi.org/10.1080/07315724.2001.10719175
  3. FL:CRC Series in Modern Nutrition Isoflavones:Souce and metabolism. Hanbook of nutraceuticals and functional foods Hendrich,S.;Murphy,P.A.;Wildman,R.E.C.(ed.)
  4. Obstet Gynecol Sury v.57 Phytoestrogens in the management of the menopause:up-to-date Ewies,A.A. https://doi.org/10.1097/00006254-200205000-00023
  5. β. Endocrinology v.139 Interaction of estrogenic chemicals and phytoestrogen receptor Kuiper,G.;Lemmen,J.;Carlsson,B.(et al.) https://doi.org/10.1210/en.139.10.4252
  6. KOREA SOYBEAN SOCIETY ISSN v.15 Soyfoods, soybean isoflavones, and bone health Messina,M.
  7. Lancet v.1 Serum bone-gla protein:a specific marker for bone formation in postmenopausal osteoporosis Brown,J.P.;Delmas,P.D.;Malaval,L.;Edouard,C.;Cahpuy,M.C.;Meunier,P.J.
  8. J Bone Miner Res v.9 Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women Szulc,P.;Arlot,M.;Chapuy,M.C.;Duboeuf,F.;Meunier,P.J.;Delmas,P.D. https://doi.org/10.1002/jbmr.5650091012
  9. J Bone Miner Res v.14 Smoking increases bone loss and decreases intestinal calcium absorption Krall,E.A.;Dawson-Hughes, B. https://doi.org/10.1359/jbmr.1999.14.2.215
  10. Caicif Tissue Int v.62 Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture Liu,G.;Peacock,M. https://doi.org/10.1007/s002239900432
  11. Clin Chem v.45 Total and free deoxypyridinoline after acute osteoclast activity inhibition Rubinacci,A.;Melzi,R.;Zampino,M.;Soldarini,A.;Villa,I.
  12. Clin Chem Lab Med v.38 Changes in bone turnover and deoxypyridinoline levels in epileptic patients Telci,A.;Cakatay,U.;Kurt,B.B.;Kayali,R.;Sivas,A.;Akcay,T.;Gokyigit,A. https://doi.org/10.1515/CCLM.2000.008
  13. Am J Med Sci v.312 Biochemical markers of bone remodeling Kleerekoper,M. https://doi.org/10.1097/00000441-199612000-00005
  14. Pharmacol Res v.36 A comparative study on biochemical markers of collagen breakdown in postmenopausal women Sirtori,P.;Sosio,C.;Polo,R.M.;Tenni,R.;Rubinacci,A. https://doi.org/10.1006/phrs.1997.0220
  15. '98 골다공증 연수강좌 새로운 약제사용측면에서 본 biochemical marker의 임상적 유용성 민용기
  16. Obstetrics & Gynecology v.87 The effect of estrogen replacement therapy on zinc in serum and urine Herzberg,M.;lusky,A.;Blonder,J.;Frenkel,Y. https://doi.org/10.1016/0029-7844(96)00044-0
  17. J Trace Elem Biol v.16 Trace mineral status in postmenopausal women:impact of hormonal replacement therapy Bureau,I.;anderson,R.A.;Arnauud,J.;Raysiguier,Y.;Favier,A.E.;Roussel,A.M. https://doi.org/10.1016/S0946-672X(02)80003-7
  18. Am J Clin Nutr v.68 Soy protein and isflavones:their effects on blood lipids and bone density in postmenoapusal women Potter,S.M.;Baum,J.A.;Teng,H.;Stillman,R.J.;Shay,N.F.;Erdman,J.R. J.W.
  19. A study of soy isoflavone supplementation effect on bone mineral density and bone metabolism markers in female college students with low bone mass Baek,S.K.
  20. The Korean Journal of Nutrition Computer Aided Nutritional Analysis Program for Professionals
  21. J Agric Food Chem v.47 Isoflavone levels in soy foods consumed by multiethnic populations in Singapore and Hawaii Franke,A.A.;Hankin,J.H.;Yu,M.C.;Maskarinec,G.;Low,S.H.;Custer,L.J. https://doi.org/10.1021/jf9808832
  22. J Korean Soc Food Sci Nutr v.29 Estimated isoflavone intake from soy products in Korean middle-aged Women Lee,S.K.;Lee,M.J.;Yoon,S.;Kwon,D.J.
  23. Clin Lab Sciences v.28 Osteocalcin:Diagnostic Methods and clinical application Power,M.J.(et al.) https://doi.org/10.3109/10408369109106867
  24. J Bone & Mineral Research v.9 Derect, enzyme-linked immunoassay for urinary deoxypyridinoline as a spectific marker for measuring bone resorption Robin,S.P.;Woitge,H.;Hesley,R.(et al.)
  25. Korean J Community Nutrition v.5 A study on dietary isoflavone intake from soy foods and urinary isoflavone excretion and, menopausal symptoms in Korean Women in Rural areas Sung,C.J.;Choi,S.H.;Kim,M.H.;Park,M.H.;Ko,B.S.;Kim,H.K.
  26. 8th Asian Congress of Nutrition Soy consumption and potential benefits for bone and heart health in the Chinese population Ho,S.C.
  27. J Epidemiol v.8 Japanese intake of flavonoids and isoflavonoids from foods Kimira,M.;Arai,Y.;Shimoi,K.;Watanabe,S. https://doi.org/10.2188/jea.8.168
  28. Am J Clin Nutr v.68 Phytoestrogens:the biochemistry, physiology,and implications for human health of soy isoflavones Setchell,K.D.R.
  29. J Bone Miner Res v.13 responses of biochemical markers of bone turnover to hormone replacement therapy:impact of biological variability Gennari,C.;Adami,S.;Naylor,K.;Eastell,R.
  30. J Nutr v.130 Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats Picherit,C.;Coxam,V.;Bennetau-Pelissero, C.;Kati-Coulibaly, S.;Davicco,M.;Lebecque,P.;Barlet,J.
  31. Br J Nutr v.85 Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomised rat Picherit,C.;Chanteranne,B.;Bennetau-pelissero, C.;Davicco,M.J.;Lebecque,P.;Barlet,J.P.;Coxam,V. https://doi.org/10.1079/BJN2000252
  32. Annual Meeting of the North American Menopause Society Soy phytoestrogens and bone Pansini,F.;Bonaccorsi,G.;Albertazzi,P.;Costantino,D.;Valerio,A.;Negri,C.;Ferrazzini,S.;Bonocuore,I.;De aloysio, D.;Fontana,A.;Pansini,N.;Mollica,G.
  33. Original research v.21 Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal Japanese women:A four-week study Uesugi,T.;Fukui,Y.;Yamori,Y.
  34. J Bone Miner Res v.17 Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women:a randomized double blind placebo-controlled study Morabito,N.;Crisafulli,A.;Vergara,C.;Gaudio,A.;Lasco,A.;Frisina,N.;D'Anna, R.;Corrado,F.;Pizzoleo,M.A.;Cincotta,M.;Altavilla,D.;Lentile,R.;Squadrito,F. https://doi.org/10.1359/jbmr.2002.17.10.1904
  35. Lab test 2000 directory Lee,G.N.;Mun,H.R.;Lee,E.H.
  36. Biomed & Pharmacother v.49 Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis Cecchettin,M.;Bellometti,S.;Cremonesi,G.;Solimeno,L.P.;Torri,G. https://doi.org/10.1016/0753-3322(96)82691-6
  37. Calcif Tissue Int v.67 Bone Mass and Markers of bone and calcium metabolism in postmenopausal women treated with 1, 25-Dihydroxyvitamin D (Calcitriol) for Four years Sairanen,S.;Karkkainen,M.;Tahtela,R.;Laitinen,K.;Makela,P.;Lamberg-Allardt, C.;Valimaki,M.J. https://doi.org/10.1007/s00223001118
  38. J Gerontol a Biol Sci Med Sci v.57 Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men Christmas,C.;O'Connor, K.G.;Harman,S.M.;Tobin,J.D.;Munzer,T.;Bellantioni,M.F.;Clair,C.S.;Pabst,K.M.;Sorkin,J.D.;Blackman,M.R. https://doi.org/10.1093/gerona/57.1.M12
  39. Calcif Tissue Int v.55 Hormone replacement therapy increases serum 1, 25-dihydroxyvitamin D;A 2-year prospective study van Hoof, H.J.;van der Mooren, M.J.;Swinkels,L.M.;Rolland,R.;Benraad,T.J. https://doi.org/10.1007/BF00298554
  40. J Bone Miner Res v.14 Evidence for involvement of 17 β-estradiol in intestinal calcium absorption independent of 1, 25-dihydroxyvitamin D3 levels in the Rat Colin ,E.M.;Van Den Bend, G.J.;Van Aken, M.;Christakos,S.;Dejonge,H.R.;Deluca,H.F.;Prahl,J.M.;Birkenhager,J.C.;Buurman,C.J.;Pols,H.A.;Van Leeuwen, J.P. https://doi.org/10.1359/jbmr.1999.14.1.57
  41. J Bone Miner Res v.14 Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat Ten Bolscher, M.;netelenbos,J.C.;Barto,R.;Van Buuren, L.M.;vander vijgh, W.J. https://doi.org/10.1359/jbmr.1999.14.7.1197
  42. J Clin Endocrinol Metab v.74 Marked diurnal variation in urinary excretion of pyridinium crosslinks in premenopausal women Schlemmer,A.;Hassager,C.;Jensen,S.B.;Christiansen,C. https://doi.org/10.1210/jc.74.3.476
  43. Principles of Nutritional Assessment Gibson,R.S.
  44. Paraplegia v.18 Zinc and osteoporosis in patients with spinal cord injury Ohry,A.;Shemesh,Y.;Zak,R.;Herzberg,M. https://doi.org/10.1038/sc.1980.30
  45. J Bone Miner Res v.5 Zinc excretion in osreoporosis women Herzberg,M.;Foldes,J.;Steinberg,R.;Menczel,J. https://doi.org/10.1002/jbmr.5650050308
  46. Orv Hetil v.134 Zinc excretion in oseroporosis women Szathmari,M.;Steczek,K.;Szucs,J.;Hollo,I.
  47. Age Ageing v.24 Zinc, biochemical markers of nutrition, and type I osteoporosis Relea,P.;Revilla,M.;Ripoll,E.;Arribas,I.;Villa,L.F.;Rico,H. https://doi.org/10.1093/ageing/24.4.303